ActivaScrew™ Interference TCP -Biocomposite Interference Screw

ActivaScrew™ Interference TCP is an advanced absorbable biocomposite interference screw for fixation of tissue, including ligament or tendon to bone, or a bone-tendon to bone in the presence of appropriate immobilization or controlled mobilization. Interference fixation is appropriate for surgeries of knee, shoulder, elbow, ankle, foot and hand/wrist. Complete absorption takes place within approximately two years, thus eliminating the need for implant removal surgery.

Individually sterile-packaged.

Enhanced tissue attachment and new bone formation with osteoconductive β-TCP and optimized TCP particle size.

Excellent in pediatric orthopedics.

Biocomposite with fully absorbable PLGA mixed with osteoconductive β-tricalcium phosphate (TCP).

For fixation of tissue, including ligament or tendon to bone, or a bone-tendon to bone in the presence of appropriate immobilization/controlled mobilization

ActivaScrew Interference TCP is an implant with excellent mechanical properties created by the tailored material and the proprietary manufacturing technique. The implant provides excellent strength retention over the bone healing period.

The ActivaScrew Interference TCP is manufactured from absorbable, self-reinforced PLGA filled with β-TCP with patented Self-Locking SL™ technology. β-TCP is recognized as an osteoconductive ceramic and it offers exceptional biocompatibility with natural bone components. The technology enables the implant’s diameter to expand 1-2% in the physiological environment and fixes the implant firmly to the bone. Product range starts from the world’s smallest biocomposite screw and it offers 30% more pull-out strength than the market leader due to the self-reinforcement technology.

Learn more about Activa technology

Patient Benefits

Patented Self-Locking SL™ Technology

ActivaScrew Interference TCP’s patented Self-Locking SL™ technology enables 1–2% expansion under human conditions, enhancing stability and compressing grafts tightly against the drill canal for up to 8–12 weeks postoperatively.

Absorption Within Approximately 2 years

ActivaScrew Interference TCP is absorbable and the implant degrades slowly in the span of approximately two years transferring the stress to the healing bone and assisting in the healing process.

Faster healing

The absorption of ActivaScrew Interference TCP eliminates the need for removal surgery, reducing the risk of implant-related long-term complications and facilitating a smoother healing process.

Indication Examples of Activa Series

Foot & Ankle

The Activa series applies for fractures and orthopedic conditions in foot and ankle.

  1. Forefoot fractures and deformity corrections.
  2. Midfoot and hindfoot fracture fixation and deformity corrections.
  3. Ankle fractures and syndesmotic injuries.

Availability of products and their approved intended uses and indications may vary by region. For details, please contact Bioretec customer service.

Explore More Indications

Knee

The Activa series applies for fractures and orthopedic conditions in knee.

  1. Patellar fractures and knee ligament reconstruction.
  2. Tibial epi-/metaphyseal fractures.
  3. Femoral epi-/metaphyseal fractures.

Availability of products and their approved intended uses and indications may vary by region. For details, please contact Bioretec customer service.

Explore More Indications

Upper Extremity

The Activa series applies for fractures and orthopedic conditions in Upper Extremity.

  1. Finger and hand fractures.
  2. Wrist and forearm fractures and stabilization.
  3. Elbow fractures.

Availability of products and their approved intended uses and indications may vary by region. For details, please contact Bioretec customer service.

Explore More Indications

Pediatric

The Activa implants are clinically tested for over 20 years, are used in more than 40 countries, and have helped hundreds of thousands of adult and pediatric patients.

Availability of products and their approved intended uses and indications may vary by region. For details, please contact Bioretec customer service.

Explore More Indications

Activa -The Difference

Medial malleolus fracture of a 12-year old girl with absorbable ActivaScrew™ LAG

  • From Intra Operative to 26 weeks
  • Longstanding reliability
  • Cost-effective solution

For professionals

The ActivaScrew Interference TCP™

Dimensions
Sizes start from 4 mm, the largest being 11 mm in diameter
Material
Absorbable self-reinforced poly(L-lactide-co-glycolide) (PLGA) filled β-tricalcium phosphate (TCP)
Anatomical locations
Knee, foot, ankle, elbow, shoulder and hand
Certificates
CE-approved
Open Instrument GuideShow Product Codes

The ActivaScrew Interference TCP™ documents

The ActivaScrew Interference TCP™ Product Sheet

We offer our products across all continents, and you can find the location closest to you here.